The largest database of trusted experimental protocols

29 protocols using anti ki67 fitc

1

Evaluating Cell Proliferation by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
0.5 × 106 CLBL-1 cells were harvested after 72-hour of DMSO or pevonedistat treatment. Cells first were stained with the fixable viability dye, Ghost Dye Red 780 (1:1000; Tonbo Biosciences, San Diego, CA). For intracellular Ki67 staining, cells were fixed and permeabilized using the BD Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA) and further labelled with FITC anti-Ki67 (1:20; BD Biosciences, San Jose, CA). DAPI solution (1:250; Thermo Fisher Scientific, Madison, WI) was then added and incubated overnight at 4°C. Samples were analysed on a BD LSRFortessa (BD Biosciences, San Jose, CA), and results were analysed using FlowJo v10.0.7 software.
+ Open protocol
+ Expand
2

JAK Inhibitor Effects on CLBL-1 Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 72‐hour JAK inhibitor treatment, 0.5 × 106 CLBL‐1 cells were harvested. Cells first were stained with the fixable viability dye, Ghost Dye Red 780 (Tonbo Biosciences20; 1 : 1000). For intracellular Ki67 staining, cells were fixed and permeabilized with the BD Cytofix/Cytoperm kit (BD Biosciences17) and further labeled with FITC anti‐Ki67 (BD Biosciences17; 1 : 20). DAPI solution (Thermo Fisher Scientific10; 1 : 250) then was added and incubated overnight at 4°C. Samples were analyzed the next day on a BD LSRFortessa (BD Biosciences17) and results were analyzed with FlowJo v10.0.7 software18.
+ Open protocol
+ Expand
3

Ki67-Hoechst Assay for Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Ki67-Hoechst assays, CD34+ cells with or without editing were first stained with fixable viability stain 660 (1:1000, BD) for 5 min in 37°C and were fixed with Cytofix/Cytoperm buffer (BD) for 15 min in 4°C. Cells were stained with FITC-anti-KI67 (1:25, BD, 556027) for 2hours-overnight in Permwash buffer (BD), then with Hoechst 33342 (1:5000; Life Technologies) for 5 min at RT. Samples were sorted on a Aria Fusion Cell Sorter (BD) or analyzed on a LSR Fortessa cytometer (BD). For assessment of immunophenotypic markers together with cell cycle analysis, human CD34+ cells with or without editing were stained with Percp-Cy5.5-anti-CD34 (1:50) and PE-Cy7-anti-CD38 (1:50) for 30 min in 4°C before they were stained with fixable viability stain and fixed. For assessment of cell cycle status without fixation (live cell cycle status), cells with or without editing were stained with Hoechst 33342 (1:1000, Invitrogen) for 45min in 37°C, and then were stained with Pyronin Y (1:20,000, Invitrogen) for additional 15 min in 37°C or were just stained with Pyronin Y for 15 min in 37°C. Samples were then sorted on Aria Fusion Cell Sorter (BD) or analyzed on LSR Fortessa cytometer (BD).
+ Open protocol
+ Expand
4

Quantification of CD4+ T cell activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells isolated from blood at week 13 from nine animals per group were stained with PerCPCy5.5 anti-CD4, Ax700 anti-CD3, FITC anti-Ki67 and BV650 anti-CCR5 (3A9, 5 µl) all from BD Bioscience and APC anti-α4β7 and PE-anti-CD38, provided by the NIH Nonhuman Primate Reagent Resource (R24 OD010976, and NIAID contract HHSN 272201300031C) to assess CD4+ T cell activation. The same antibody concentrations and clones, staining methods, live/dead discriminant, instruments and analysis software described in the PB section above were used here. Gating was done on live CD3+CD4+ cells, and the frequency of Ki67+ and CCR5+ cells was calculated on CD4+ T cells. The frequency of α4β7 and CD38 was calculated on Ki67+CD4+ T cells.
Cells isolated from rectal mucosa of six animals per group were stained to measure the expression of CCR5+ on CD4+ T cells. Cells were stained with CD3, CD8 and CCR5 (CTC5; 1:20 dilution, R&D), and the frequency of live CD20-CD3+CD8-CCR5+ cells was calculated.
+ Open protocol
+ Expand
5

Multiparameter Flow Cytometry of T-cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CD8+ T cells, splenocytes and thymocytes were first stained for surface antigens and then treated with Foxp3 staining buffer set according to the manufacturer's directions (eBioscience). Anti-Eomes AlexaFluor 647 or eFluor 660 (Dan11mag, 1/75), anti-T-bet PE (eBio4B10, 1/100) and anti-CD49d FITC or PE (R1-2, 1/50) antibodies were purchased from eBioscience. Anti-CD8 PercP (53–6.7, 1/50), anti-CXCR3 APC (CXCR3-173, 1/50), anti-CD4 Pe-Cy7 (RM4-5, 1/100), anti-CD62L PE (1/100) or V450 (1/50) (MEL-14), anti-Bcl2 PE (3F11, 1/25), anti-Ki67 FITC (B56, 1/25), anti-CD44 FITC or V450 (IM7, 1/50), anti-CD127 Pe-Cy7 (SB/199, 1/50), anti-CD122 FITC (TM-BETA1, 1/50), anti-NK1.1 FITC (PK136, 1/50), anti-CD90.2 Pe-Cy7 (53-2.1, 1/100) and anti-IFNγ APC or PB or PE (XMG1.21/50) were purchased from BD biosciences. Anti-CD3 Pe-Cy7 (2C11, 1/100) was purchased from Biolegend.
In some experiments, brefeldin A (5 μg ml−1, Sigma) was added in samples for 3 h at 37 °C before intracytoplasmic staining. Blood samples were directly stained for surface antigens and then treated with FACS lysing buffer (BD biosciences) as described in the product data sheet. All samples were fixed with 1% paraformaldehyde in PBS prior to their processing using a Cyan flow cytometer (Dako Cytomation).
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorochrome labeled monoclonal antibodies (mAbs) anti-CD2-FITC, anti-CD3-Alexa 700, anti-CD3-PerCP, anti-CD4-V450, anti-CD4-PE, anti-CD8-APC Fluor 780, anti-CD8-PacBlue, anti-CD16-FITC, anti-CD20 PECy7, anti-CD19-V450, anti-CD20-APCCy7, anti-CD25-PEcy7, anti- CD28-PE, anti-CD28-FITC, anti-CD38-PE, anti-CD39-FITC, anti-CD45-PerCP, anti-CD56-APC, anti-CD57-FITC, anti-CD197-PECy7, anti-HLA-DR, anti-IgM, anti-IgD, anti-Ki67-FITC, anti-Bcl-2-PE, anti-TNF-α-PE, anti-TNF-α-APC, IFN-γ-PcpCy5.5, and IL-2-PECy7 were purchased from BD Biosciences (Franklin Lakes, NJ). Anti-CD45RA-QDOT655 and anti-CD69-FITC mAb were obtained from Invitrogen (Carlsbad, CA). Anti-CD8-Alexa780, anti-CD27-Alexa Fluor 700, and anti-CD38-eFluor 650NC were obtained from E-bioscience (San Diego, CA). Anti-CD24-PEcy7 and anti-CD279-PE (PD-1) were purchased from Biolegend (San Diego, CA).
Human EBV protein and CMV peptide pool of pp65 sequence consisting of 138 peptides (15 mers with 11 amino acid overlaps) was purchased from JPT Peptide Technologies (Berlin, Germany).
All patients were DSA-free with a calculated panel reactive antibody (PRA) ≤20% at enrollment. Patient samples were assessed for donor-specific alloantibody post-transplantation as described previously (18 (link)).
+ Open protocol
+ Expand
7

Phenotypic Characterization of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following monoclonal antibodies (MAbs) were used for phenotypic analysis: (i) anti-CD27-APC-eFluor780, anti-CD45RA-phycoerythrin (PE), and anti-CD127-eFluor450 (eBioscience, San Diego, CA); (ii) anti-CD3-Pacific Blue, anti-CD8-AmCyan, anti-CD8-V500, anti-CD11a-fluorescein isothiocyanate (FITC), anti-CD95-PE, anti-Ki67-FITC, and anti-CCR7-PE-Cy7 (BD Biosciences, Heidelberg, Germany); (iii) anti-CCR7-FITC (R&D Systems); and (iv) anti-PD-1-PE-Cy7 (BioLegend, San Diego, CA). 7-Aminoactinomycin D (7-AAD; Viaprobe; BD Biosciences) was used for the exclusion of dead cells. All samples were acquired using a FACSCanto II flow cytometer (BD Biosciences) and analyzed with FlowJo software (TreeStar Inc., Ashland, OR).
+ Open protocol
+ Expand
8

Comprehensive Treg Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the Treg profile and function, 1x106 PBMCs were incubated for 15 min at room temperature with the anti-CD3-PerCP-Cy™5.5 (clone UCHT1), anti-CD4-APC-H7 (clone SK3), anti-CD8-Alexa Fluor® 700 (clone RPA-T8), anti-CD25-PE-CF594 (clone M-A251), anti-CD127-Alexa Fluor® 647 (clone HIL-7R-M21), anti-CD45RA-PE-Cy™7 (clone HI100), anti-CD39-BV650 (clone TU66), and anti-CD73-BV421 (clone AD2) monoclonal antibodies (all from BD Biosciences). Cells were then washed and fixed/permeabilized (eBioscience, catalog no. 00-5521-00) using FOXP3 staining buffer (eBioscience, catalog no. 00-5523-00), and finally stained with the combination of conjugated antibodies anti-Ki67-FITC (BD Biosciences, catalog no. 556026) and anti-FOXP3-PE (BD Biosciences, clone 259D/C7) for nuclear epitope staining. Next, cells were washed with PBS, fixed with 1% formaldehyde in PBS (Sigma-Aldrich, catalog no. 1004960700) for 15 min at room temperature and analyzed by flow cytometry.
+ Open protocol
+ Expand
9

Multiparametric Flow Cytometry for T Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were mixed gently with anti-CD4-FITC and anti-CD25-APC, and anti-CD8-APC antibodies (BD Pharmingen™, USA) respectively and incubated for 30 min at 4 °C, and washed twice. Then, fixed, permeabilized, and stained with anti-Foxp3-PE, anti-IFNγ-PE-CY7, anti-IL4-APC-CY7, anti-IL17-BV421, anti-TNFα-Percpcy5.5, anti-Ki67-FITC, anti-Granzyme B-PE, and anti-TGFβ-APC (BD Pharmingen™, USA) for analysis of T cells. The samples were performed by flow cytometry on a FACS Aric III flow cytometer (BD Biosciences, USA). Flow cytometry data were analyzed using FlowJo software 10.4.
+ Open protocol
+ Expand
10

Multiparameter Flow Cytometry Immunoassay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for surface staining included anti-CD14 Qdot 655, anti-CD20 Qdot 655, anti-CD4 PeCy5.5, anti-CD8 Qdot605 (Invitrogen; Carlsbad, California), anti-CD14 BV650, anti-CD20 BV650 (Biolegend; San Diego, California), anti-CD28 ECD (Beckman Coulter; Fullerton, CA), anti-CD25 APC-Cy7, anti-CD95 PE-Cy5, and anti-HLA-DR APC (BD Pharmingen; San Diego, California). Antibodies used for intracellular staining included anti-interleukin-2 (IL-2) Alexa700 (Biolegend), anti-interferon-gamma (IFNγ) Alexa 700 (Invitrogen), anti-tumor necrosis factor-alpha (TNFα) Alexa 700, anti-CD3 Pac Blue, anti-CD69 PE, and anti-Ki67 FITC (BD Pharmingen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!